Science

Raymond Chan: Neuroactive ligand-receptor and RAS pathway disruptions linked to cancer-related cognitive impairment

Raymond Chan/LinkedIn

Mar 12, 2025, 16:34

Raymond Chan: Neuroactive ligand-receptor and RAS pathway disruptions linked to cancer-related cognitive impairment

Raymond Chan, Deputy Vice-Chancellor for Research at Flinders University, shared a post on X about a paper he co-authored with colleagues published in Supportive Care in Cancer:

“In our recent gene expression study, Neuroactive ligand-receptor interaction and RAS pathways were significantly perturbed btn cancer survivors with and without cancer-related cognitive impairment directions re potential therapeutics.”

“Perturbations in the neuroactive ligand-receptor interaction and renin angiotensin system pathways are associated with cancer-related cognitive impairment”

Authors: Raymond Chan, Adam Walker, Janette Vardy, Alexandre Chan, Kate Oppegaard, Adam Olshen, Marilyn Hammer, Jon Levine, Christine Miaskowski et al.

More posts featuring Raymond Chan.

Adam Olshen Adam Walker Alexandre Chan cancer cancer related cognitive impairment Christine Miaskowski Janette Vardy Jon Levine Kate Oppegaard Marilyn Hammer neuroactive ligand-receptor interaction OncoDaily Oncology Raymond Chan renin angiotensin system

FDA approval: Pembrolizumab for HER2 positive gastric or GEJ adenocarcinoma expressing PD-L1 (CPS ≥1): KEYNOTE-811 Trial

Changing the Future of Adolescent and Young Adult Cancer Care

OncoDaily Launches New Social Channel on Telegram – @OncoDaily

In Memory of Chadwick Boseman and His Colon Cancer Battle

Groundbreaking Canadian Cancer Society-funded research aims to reshape the future of advanced cancer